APA (7th ed.) Citation

JM, C., AS, D., J, K., N, F., GD, W., & PA, R. (2026). Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients. Journal of the National Comprehensive Cancer Network : JNCCN, 24(3), 128. https://doi.org/10.6004/jnccn.2025.7119

Chicago Style (17th ed.) Citation

JM, Cannova, DuVall AS, Kline J, Feinberg N, Wool GD, and Riedell PA. "Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients." Journal of the National Comprehensive Cancer Network : JNCCN 24, no. 3 (2026): 128. https://doi.org/10.6004/jnccn.2025.7119.

MLA (9th ed.) Citation

JM, Cannova, et al. "Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients." Journal of the National Comprehensive Cancer Network : JNCCN, vol. 24, no. 3, 2026, p. 128, https://doi.org/10.6004/jnccn.2025.7119.